Carl Icahn’s Proxy Fight With Illumina Comes to a Vote

Shareholders are set to vote on Thursday whether to back the gene-sequencing company’s incumbent board or candidates named by the activist investor.

rssfeed
Author: rssfeed

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *